Replies to post #92763 on $heff's $tation of $tocks & $olid DD

[kklar1]

$PETX $3.09 This was on a run as well, closing the day up 14%+. Here again, I sold all but a toe-hold and intend to keep watching this one. I locked in gain 6% ($642) and will look to re-enter on any pull back as we approach the catalyst dates.

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced the Company filed an administrative New Animal Drug Application (NADA) with the Food and Drug Administration's Center for Veterinary Medicine (CVM) for Galliprant® for the control of pain and inflammation in dogs with osteoarthritis. The Animal Drug User Fee Act (ADUFA) date for approval is set for March 25.